Adverse effects associated with intrathecal chemotherapy for leptomeningeal disease
Journal of Oncology Pharmacy Practice
Published online on February 17, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
ObjectiveTo review the safety and tolerability of intrathecal (IT) chemotherapy used in the treatment of leptomeningeal disease (LMD) from solid and hematologic malignancies, with emphasis on agent-specific toxicity profiles and delivery-associated ...
ObjectiveTo review the safety and tolerability of intrathecal (IT) chemotherapy used in the treatment of leptomeningeal disease (LMD) from solid and hematologic malignancies, with emphasis on agent-specific toxicity profiles and delivery-associated ...